<code id='56652A9017'></code><style id='56652A9017'></style>
      • <acronym id='56652A9017'></acronym>
      <center id='56652A9017'><center id='56652A9017'><tfoot id='56652A9017'></tfoot></center><abbr id='56652A9017'><dir id='56652A9017'><tfoot id='56652A9017'></tfoot><noframes id='56652A9017'>
      • <optgroup id='56652A9017'><strike id='56652A9017'><sup id='56652A9017'></sup></strike><code id='56652A9017'></code></optgroup>
        5. <b id='56652A9017'><label id='56652A9017'><select id='56652A9017'><dt id='56652A9017'><span id='56652A9017'></span></dt></select></label></b><u id='56652A9017'></u>
          <i id='56652A9017'><strike id='56652A9017'><tt id='56652A9017'><pre id='56652A9017'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / knowledge / leisure time      
           
     
           
      
          leisure time 
           
      
           
      
           
       2025-09-29 05:40:29 
   
      
           
      
           
                        
          leisure time  
          
                                   
                 
                                      author：leisure time   
                                        
                                      
                                      Page View：58596
                                  
                                    
          
                                   
          Franklin faces
          Adobe
          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.
          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.
          advertisement
          Arch declined to comment on the new fundraising.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          How CRISPR works, explained in two minutes
                                
                            
          Next article：  
                                      
                                          How to save PrEP access — and even expand it
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles